China NMPA clears IND for Akeso’s trispecific antibody
Akeso Inc.’s first-in-class trispecific antibody, AK-150, has received IND clearance from China’s Na...
Publisher
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Akeso Inc.’s first-in-class trispecific antibody, AK-150, has received IND clearance from China’s Na...
Source route
Continue on bioworld.com
Leave the platform to read the original full article on the publisher site.
Source: BioWorld NMPA RSS
Scope: Regulatory
Related coverage
More related coverage
Update on escalating conflict in the Eastern Mediterranean Region
17 March 2026 – Conflict in the Middle East continues to escalate, unfolding a multi-layered public...
WHO releases US$2 million in emergency funds to support health response in Lebanon, Iraq and Syria
15 March 2026, Cairo, Egypt — As humanitarian health needs continue to rise across parts of the Midd...
Conflict deepens health crisis across Middle East, WHO says
WHO Representative in Lebanon and team visit the Dekwaneh shelter in Beirut, hosting internally disp...
Statement by Dr Hanan Balkhy, Regional Director WHO Eastern Mediterranean Region Palais Briefing on Impact of the recent escalation on the health situation in EMR
6 March 2026Today, 115 million people across the Eastern Mediterranean Region require humanitarian a...